- Open
- 5.80
- High
- 5.70
- Low
- 5.50
- Close
- 5.50
- Change
- -0.30 (-5.17%)
- Volume
- 70,084
| 29 Oct 2026 | 07:00:04 | Release of Video Updates on Investor Hub |
| 17 Sept 2026 | 07:00:01 | Half-year Financial Report |
| 15 Sept 2026 | 07:00:06 | OptiBiotix Ltd Directorate Changes |
| 8 Sept 2026 | 07:00:02 | SweetBiotix® Update |
| 4 Jul 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 8 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) |
OptiBiotix Health plc is a life sciences company focused on developing products aimed at improving health through the gut microbiome. Its primary offerings include SlimBiome®, a weight management product that reduces hunger and cravings, and WellBiome®, a prebiotic fiber complex that enhances gut health and supports overall wellbeing. The company also develops SweetBiotix®, a natural sugar substitute, and microbiome modulators for various health applications. OptiBiotix operates globally, targeting consumers seeking healthier lifestyle choices and partners in the nutraceutical and pharmaceutical sectors.
| 29 Oct 2026 | 07:00:04 | Release of Video Updates on Investor Hub |
| 17 Sept 2026 | 07:00:01 | Half-year Financial Report |
| 15 Sept 2026 | 07:00:06 | OptiBiotix Ltd Directorate Changes |
| 8 Sept 2026 | 07:00:02 | SweetBiotix® Update |
| 4 Jul 2026 | Annual Report and Accounts (to 2025-12-31) | |
| 8 Jul 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 7 Jul 2024 | Annual Report and Accounts (to 2023-12-31) |
OptiBiotix Health plc is a life sciences company focused on developing products aimed at improving health through the gut microbiome. Its primary offerings include SlimBiome®, a weight management product that reduces hunger and cravings, and WellBiome®, a prebiotic fiber complex that enhances gut health and supports overall wellbeing. The company also develops SweetBiotix®, a natural sugar substitute, and microbiome modulators for various health applications. OptiBiotix operates globally, targeting consumers seeking healthier lifestyle choices and partners in the nutraceutical and pharmaceutical sectors.
| 2 Sept 2026 |
| 07:00:07 |
| H&B launches FORMI™ Product containing SlimBiome® |
| 14 May 2026 |
| Market movers: Cisco Systems, Ideal Power, Snail, Klarna… |
| 14 May 2026 | AIM movers: TheraCryf progresses towards Ox-1 phase 1 trial and ex-dividends |
| 14 May 2026 | OptiBiotix shares surge 13.5% as company plans SweetBiotix showcase for investors |
| 1 Apr 2026 | AIM movers: Deltic Energy bid lapses and Insig AI considers Nasdaq listing |
| 17 Feb 2026 | AIM movers: Cora Gold retail offer oversubscribed and MTI Wireless Edge ahead of expectations |
| 21 Jan 2026 | AIM movers: Goldstone Resources premium fundraising and Firering Strategic Minerals takes up option |
| 2 Sept 2026 |
| 07:00:07 |
| H&B launches FORMI™ Product containing SlimBiome® |
| 14 May 2026 |
| Market movers: Cisco Systems, Ideal Power, Snail, Klarna… |
| 14 May 2026 | AIM movers: TheraCryf progresses towards Ox-1 phase 1 trial and ex-dividends |
| 14 May 2026 | OptiBiotix shares surge 13.5% as company plans SweetBiotix showcase for investors |
| 1 Apr 2026 | AIM movers: Deltic Energy bid lapses and Insig AI considers Nasdaq listing |
| 17 Feb 2026 | AIM movers: Cora Gold retail offer oversubscribed and MTI Wireless Edge ahead of expectations |
| 21 Jan 2026 | AIM movers: Goldstone Resources premium fundraising and Firering Strategic Minerals takes up option |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £2.13bn | +0.6% | |
| £175m | +0.2% | |
| £100m | -0.1% | |
| £9m | -0.7% | |
| £7m | -0.6% | |
OPTIOptibiotix Health plc | £6m | -0.3% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
| £2.13bn | +0.6% | |
| £175m | +0.2% | |
| £100m | -0.1% | |
| £9m | -0.7% | |
| £7m | -0.6% | |
OPTIOptibiotix Health plc | £6m | -0.3% |